These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7195223)

  • 1. [Comparison of blood levels, excretion and metabolite pattern in rats non-pretreated and pretreated with subacute doses of AR-L 115 BS].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):209-12. PubMed ID: 7195223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
    Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of AR-L 115 BS in rabbits and dogs].
    Zimmer A; Hammer R
    Arzneimittelforschung; 1981; 31(1a):212-6. PubMed ID: 7195224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human pharmacokinetics of AR-L 115 BS (author's transl)].
    Roth W; Zimmer A; Busch U
    Arzneimittelforschung; 1981; 31(1a):236-9. PubMed ID: 7195229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal studies on the tolerability of AR-L 115 BS (author's transl)].
    Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H
    Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the positive-inotropic activity of the benzimidazole derivative AR-L 115 BS in isolated guinea pig atria.
    Dahmen M; Greeff K
    Arzneimittelforschung; 1981; 31(1a):161-5. PubMed ID: 7195212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium transport in sarcoplasmic reticulum in the presence of AR-L 115 BS].
    Hasselbach W
    Arzneimittelforschung; 1981; 31(1a):191-3. PubMed ID: 7195219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
    Schrader J
    Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
    Thormann J; Kramer W; Schlepper M
    Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiments with AR-L 115 BS on skinned cardiac fibers.
    Trube G; Trautwein W
    Arzneimittelforschung; 1981; 31(1a):185-8. PubMed ID: 7195217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
    Nebel W; Sabin G; Surawitzki G
    Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic assay of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo-[4,5-c] pyridine hydrochloride, a potent cardiotonic agent, and two metabolites in plasma.
    Bernstein JR; Franklin RB
    J Chromatogr; 1985 Jul; 342(1):228-33. PubMed ID: 3840172
    [No Abstract]   [Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS.
    Kutter E; Austel V
    Arzneimittelforschung; 1981; 31(1a):135-41. PubMed ID: 7195206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new orally active positive inotropic substance: AR-L 115 BS.
    Ruffmann KD; Mehmel HC; Kübler W
    Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
    Benedikter L; Mey T
    Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.